Study ID: TV1106-IMM-20001 | 2013-004468-69

Study Title

A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children

Teva Identifier

TV1106-IMM-20001 | 2013-004468-69

ClinicalTrials.gov Identifier

NCT02092077

Study Status

Terminated

Trial Condition(s)

Growth Hormone-Deficiency

Interventions

Drug: TV-1106 | Drug: somatropin

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
muscle icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

3 Years to 11 Years

Trial Duration

April 30, 2014 - August 31, 2016

Phase

Phase 2

Study Type

Interventional